PD-1 INHIBITORS

Clinical trials for PD-1 INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new PD-1 INHIBITORS trials appear

Sign up with your email to follow new studies for PD-1 INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Completed 1

Triple therapy boosts survival in tough liver cancer cases

Disease control Completed

This study tested whether adding a liver-directed chemotherapy infusion (HAIC) to the usual combination of lenvatinib and an immunotherapy drug (PD-1 inhibitor) helps people with advanced liver cancer that has spread into the main blood vessel of the liver. 244 patients with high…

Matched conditions: PD-1 INHIBITORS

Sponsor: First Hospital of China Medical University • Aim: Disease control

Last updated Jun 16, 2026 23:35 UTC

PD-1 INHIBITORS

Get alerted when new PD-1 INHIBITORS trials appear

Triple therapy boosts survival in tough liver cancer cases